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Abstract 
Posterior circulation vascular occlusive dis-
ease  in  children  is  a  rare  and  uncommonly
reported event. Among the numerous risk fac-
tors, the methylenetetrahydrofolate reductase
(MTHFR) mutation is considered to be a com-
mon genetic cause of thrombosis in adults and
children. Recently, a link between the MTHFR
mutation  and  cerebrovascular  disorders  was
reported in children. Diffusion tensor imaging
(DTI) is a great improvement on magnetic res-
onance  imaging  (MRI),  making  the  in  vivo
anatomical and pathological study of the brain
and its fibers possible. In our patient cerebel-
lar  infarction  was  associated  with  MTHFR
mutation  and,  in  a  standard  neurological
examination, DTI revealed normal white mat-
ter tracts. 
Introduction
Posterior circulation vascular occlusive dis-
ease  is  rare  in  children  whereas  in  adults
underlying  vascular  disease  accounts  for  a
high percentage of posterior circulation infarc-
tion.  The  most  commonly  reported  cause  of
vertebrobasilar occlusion in children is trau-
matic injury to the cervical vertebral artery.
1
Recently, a link between the methylenetetrahy-
drofolate reductase (MTHFR) mutation, which
is considered to be a common genetic cause of
thrombosis in adults and children, and cere-
brovascular  disorders  was  reported  in  chil-
dren.
2 The observation that most children with
the MTHFR mutation do not present with cere-
brovascular disorders may be a result of the
requirement for additional thrombogenic risk
factors.
3 However,  the  concurrent  effects  of
other circumstantial or genetic thrombogenic
risk factors have not been established clearly,
and further studies are needed to determine
which associated exogenous and endogenous
risk  factors  predispose  infants  with  the
MTHFR mutation to cerebrovascular disorders.
We  report  on  a  patient  in  whom  cerebellar
infarction was associated with MTHFR homo  -
zygous mutation.
Case Report
Our patient, a boy, was born at 36 weeks’
gestation by normal vaginal delivery and had
Apgar scores of 9 and 10 after 1 and 5 minutes.
The  family  history  was  positive  for  vascular
disorders:  two  relatives  died  from  heart
attacks.  Neurological  developmental  mile-
stones were normal according to age. At the
age of seven years the child was hospitalized
for head trauma with consequent vertigo and
vomiting. No changes were observed on neuro-
radiological investigation and the neurological
examination  was  normal.  At  the  age  of  13
years  he  had  an  acute  episode  of  headache
associated with vomiting. For these reasons he
was  referred  to  our  Pediatric  Emergency
Department  where  he  presented  with  head  -
ache, further vomiting, and marked vertigo. On
neurological  examination  he  showed  no
meningeal  signs,  no  deficit  of  the  cranial
nerves, a positive Romberg’s sign, difficulty in
performing  coordination  tests,  and  marked
ataxia.  In  addition,  nystagmus  was  present
bilaterally.  A  CT  scan  was  performed  and
demonstrated a marked hypodense lesion in
the left cerebellar hemisphere. Magnetic reso-
nance  imaging  (MRI)  showed  four  areas  of
hyperintensity  signal  in  T2  and  Flair  views
without  contrast  enhancement.  These  areas
where  localized  in  the  left  cerebellar  hemi-
sphere, inferior part of the vermis, and right
cerebellar  hemisphere,  respectively.  Further  -
more,  slight  compression  laterally  on  the
fourth ventricle was observed. This picture was
compatible with multiple cerebellar ischemic
areas (Figure 1).
The boy was hospitalized and rapidly started
on  anticoagulant  therapy.  High  molecular
weight heparin was administered according to
the  following  schedule:  75  U/kg  given  intra-
venously over ten minutes, followed by a main-
tenance dose of 18 U/kg/h for ten days. Then
the child was treated with oral anticoagulants
(dicoumarol), monitoring coagulation parame-
ters daily, and maintaining an INR index of
between 2 and 3. The anticoagulation regimen
was  administered  over  two  months,  then
dicoumarol was substituted with aspirin (100
mg/day). Furthermore, since the boy’s diet was
poor  in  vitamins,  a  multivitamin  was  given
with  the  antiplatelet  agent,  notwithstanding
the incompletely established role of vitamins
in  preventing  endothelial  damage.  Over  the
next  few  days  extensive  coagulation  studies
were  performed,  including  a  complete  blood
count.  Prothrombin  time,  activated  partial
thromboplastin  time,  concentrations  of  total
and free protein S, and antithrombin III were
normal; protein C was low (70%; normal range
70-140%).  In  addition,  serum  cholesterol,
triglycerides,  high-density  lipoprotein,  low-
density  lipoprotein,  homocysteine,  and  com-
plement  components  C3  and  C4  concentra-
tions were normal. Lupus anticoagulant tests
and  serum  titers  of  anticardiolipin  IgG  and
IgM, β2 glycoprotein 1 IgG and IgM, and anti-
nuclear and anti-DNA antibodies were normal.
An  evaluation  for  the  prothrombin  G20210A
gene mutation was negative. The patient was
found  to  be  heterozygous  for  the  factor  V
Leiden  mutation  and  homozygous  for  the
677TT mutation of the MTHFR gene by poly-
merase chain reaction analysis; factor VII was
normal. Moreover, the father was found to be
homozygous for the MTHFR mutation and the
mother  was  heterozygous  for  the  MTHFR
mutation. 
A  cardiac  evaluation  including  electrocar-
diography and echocardiography was normal,
and no other cause for the cerebral infarction
in the child was found. A second MRI together
with diffusion tensor imaging (DTI) confirmed
the previous findings of cerebellar damage of
recent origin. MRI of the neck showed changes
at the level of the left external carotid artery
and left vertebral artery. Over the next few days
the  clinical  condition  of  the  boy  improved
markedly. MRI performed one month after the
event was stable. The boy was discharged from
the Pediatric Department in a good neurologi-
cal condition; no clinical signs of neurological
deficit  were  observed.  A  follow-up  MRI
remained stable; no other episodes of stroke
were observed. During the two years and six
months of follow-up, MRI plus DTI revealed a
stable neuroradiological picture of the lesion
previously observed and no anomalies of the
major white matter tracts, such as corpus cal-
losum,  superior  longitudinal  fasciculus,  and
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corticospinal tracts. At present the boy is in
good clinical health. 
Discussion
The  clinical  presentation  of  cerebellar
infarction is diverse, and can resemble many
other disorders. The main symptoms of dizzi-
ness,  nausea  and  vomiting,  gait  instability,
and headache are nonspecific, and are caused
usually by more common and benign disor-
ders. The important components of the neuro-
logical examination that help to identify cere-
bellar  stroke:  coordination,  gait,  and  eye
movements,  are  commonly  omitted  or
abridged  in  primary  care,  particularly  when
symptoms might not suggest a central nerv-
ous system cause. Headache is more common
in strokes in the posterior circulation than in
the  anterior  circulation,  and  particularly  in
cerebellar  infarction  with  nearly  40%  of
patients with cerebellar infarction presenting
with a headache. Notably, in our patient the
main clinical symptom was a posterior thun-
derclap headache. Although the superior cere-
bellar artery is the largest branch of the verte-
brobasilar  tree,  a  superior  cerebellar  artery
territory infarction is much less common than
the  posterior  inferior  cerebellar  artery  syn-
drome  of  Wallenberg.
4 Isolated  cerebellar
artery  infarctions  have  been  reported  in
adults,
4 but  cerebellar  infarction  is  a  rare
event in children and the young adult. The
mechanism  of  such  infarctions  may  be  an
artery-to-artery  embolism  from  the  verte-
brobasilar arteries, a cardiac source of emboli
(patent foramen ovale), dissection, or fibro-
muscular dysplasia of the superior cerebellar
artery.
5 Among  the  risk  factors  for  cerebral
stroke,  the  MTHFR  mutation  might  lead  to
elevation  of  the  plasma  concentrations  of
homocysteine,  which  has  been  associated
with an increased risk of ischemic stroke.
2,6-7
However, this mutation might exert its effect
via a mechanism other than elevating homo-
cysteine concentrations. Factor V Leiden rep-
resents the most common mutation of Factor
V. It is a result of a point mutation at nucleo  -
tide 1691 of the FV gene, inducing an Arg-506-
Glu substitution in the FV protein. The conse-
quence of this mutation is the loss of one of
three sites of cleavage for activated protein C
(aPC)  in  the  FV  molecule,  so  when  aPC  is
added  to  the  plasma  from  patients  with
Leiden, it resists the anticoagulant effect of
aPC on thrombotin production. This phenom-
enon is known as aPC resistance (aPCR). It
has been reported that there is a prevalence
for FV Leiden of 20-60% in white persons with
thrombosis. The heterozygous state increases
the risk for thrombosis up to 10%, while the
homozygous  condition  increases  the  risk
50,100-fold.
8 While  FV  Leiden  represents  a
well-demonstrated  risk  for  thrombosis,  the
question about the role of the C677T polymor-
phism  of  the  MTHFR  gene  in  thromboem-
bolism includes some aspects that need to be
discussed.  First,  although  the  relationship
between the increased homocysteine plasma
level and cardiovascular diseases is well-doc-
umented,  the  molecular  mechanism  of
endothelial  damage  still  is  not  completely
understood.  Second,  the  677C>T  polymor-
phism in the homozygous as well as the het-
erozygous state is not associated always with
an  increased  Hct  level.  Meta-analyses  have
supported  these  observations.  For  example,
Kelly and co-workers
9 reported a 21% greater
mean value for homocysteine plasma levels in
patients  with  stroke,  but  the  homozygous
state of the mutation (MTHFR 677TT geno-
type)  did  not  show  statistical  significance.
9
We  found  the  homozygous  mutation  of  the
MTHFR gene originating from the father can
be considered the only risk factor for vascular
accidents. The changes at the level of the left
external carotid artery may be considered a
normal anatomical variant and not a potential
risk factor. 
DTI is a great improvement on MRI in brain
investigations, enabling the in vivo study of
the anatomical and pathological structures of
the brain and fiber tracts. Compared with rou-
tine MRI, DTI has many advantages. First, it
finds  the  focal  site  of  ultra-acute  cerebral
infarction that is displayed poorly by routine
MRI; second, it clearly reveals the interruption
of white matter fibers; third, it has a higher
rate of spatial resolution and fewer artifacts;
fourth,  DTI-generated  color  tensor  images
reveal the relationship between the region of
cerebral ischemia and the damaged fibers, and
the three-dimensional fibrous reconstruction
clearly  presents  the  condition  of  the  corti-
cospinal  tracts.
10 In  our  patient,  DTI  demon-
strated  the  normality  of  the  white  matter
tracts. This finding is in accordance with the
normal neurological condition of the boy and
the absence of neurological consequences of
the cerebellar stroke. As previously reported,
structural abnormalities of white matter fibers
are  the  dominant  pathological  change  after
cerebral ischemia and infarction. Such patho-
logical changes in the microstructure of brain
tissue may lead to severe ischemic stroke. In
recent years, DTI has emerged as a noninva-
sive  method  to  study  the  structure  of  brain
white matter fibers in vivo and is promising in
the evaluation of ischemic brain injury.
10
In  conclusion,  when  there  are  no  other
causes for cerebellar infarction, MTHFR muta-
tion must be investigated. For example, when
a  pediatric  patient  presents  with  acute
headache, a screening test for a genetic cause
of thrombosis should be performed, together
with MRI with DTI where possible. MRI should
Case Report
Figure  1.  (A)  and  (B)  T2-weighted  axial  views
showing four areas of hyperintensity signal with-
out contrast enhancement. These areas are local-
ized in the left cerebellar hemisphere, inferior part
of the vermis, and right cerebellar hemisphere.
Note  the  slight  compression  laterally  on  the
fourth  ventricle.  (C)  Diffusion  tensor  imaging
with fiber tracking, showing no anomalies of the
major white matter tracts; corpus callosum (red),
superior longitudinal fasciculus (blue), and corti-
cospinal tracts (green).
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be preferred to a CT scan in the pediatric age-
group. Moreover, DTI seems to be the neurora-
diological investigation of choice to evaluate
the clinical and neuroradiological follow-up.
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